While psychiatrists are turning to psychedelics, the Bakersfield treatment center says ketamine is offering news of hope to patients

Deirdra O’Neill had almost lost hope. A 44-year-old paramedic was diagnosed with multiple autoimmune disease, degenerative disc disease, and suffered from post-traumatic stress disorder. She often fought and weakened severe pain.

“I had to quit my job and was declared permanently disabled,” she said in a recent telephone interview. “I lived for my children. That’s the only reason I’ve tried fighting things in order to live. “

But after receiving a new form of psychotherapy, she feels like she has a new guilt in her life. Her pain subsides, PTSD subsides, and she says she can no longer take some of the prescribed narcotics.

“At the end of the first week of treatment, I was able to ride a bike with my husband the next day. I went to LA and walked around the Harley store, ”she said. I could do it. “Then I turned around and went to the Dodgers game and walked around Dodgers Stadium.”

The treatment, the ketamine injection, arrived in Bakersfield in 2019. During the pandemic, the clinic treating O’Neill, the ketamine infusion center, mainly flew under the radar. After acquiring the psychedelics wellness platform Delic Corp. however, the company hopes to grow rapidly over the next few years.

Ketamine is an anesthetic known for its use as a sedative in horses, as well as for its hallucinogenic effects. Recently, this drug was directed for its therapeutic use. Ketamine is believed to be the forerunner of the future as psychiatry, due to its therapeutic nature, increasingly turns to psychedelics.

Ketamine, the only psychedelic legally available to non-clinical patients, has been approved by the U.S. Food and Drug Administration for the treatment of patients with treatment-resistant depression and suicidal ideation.

In Bakersfield, the ketamine infusion center treats patients by injecting the drug through IV. The patient sits in a dimly lit room and listens to music for about an hour. Some people take a nap.

Matt Stang, CEO of Delic Corp, said, “While the association with ketamine is lost, it can be treated without depression, anxiety, or obsessive-compulsive disorder. That’s how it works. “

He described the process as restarting the brain, like pressing CTRL + ALT + DEL on a faulty computer.

Research on this topic, a relatively new frontier in psychiatry, has increased recently, but many scientists need more research to fully understand the therapeutic potential of drugs like LSD and MDMA. Is called. Experts also warn that people with known personality disorders like schizophrenia seek treatment.

However, an article in the New York Times earlier this month referred to experts who said it was only a matter of time before the FDA approved more drugs for psychiatric use. According to the story, the nightclub-related psychotropic drug MDMA could get approved by 2023, and the fungal psychedelic compound psilocybin could get approved a year or two later. There are.

“In a few years, there will be a huge psychedelic clinic within driving distance of most of the big cities because people understand that when there is no other choice, this is the way to go.” Said Stang.

For treatment at the Bakersfield Center, people need referrals from their health care providers. Insurance companies can pay for certain treatments.

For Delic’s program director, Sonny Diaz, he saw improvements in his own mother, who was being treated with ketamine for chronic depression. He wants therapeutic technology to become mainstream acceptance.

“The big driving force in the ketamine world right now is to actually demonstrate the effectiveness of ketamine so that insurers can actually start using it as a method,” he said. “I think the data will be released soon and I hope we can make it available to more people.”

It may seem surprising that the treatment took hold in Bakersfield, but the word is widely used. Soon the drug will be available for many diseases.

“I’m going to tell everyone about ketamine,” O’Neill said, saying she still had autoimmune diseases and minor chronic pain. “It’s not a cure, but it’s a great cure.”

While Psychiatrists Turn to Psychedelics, Bakersfield Treatment Center Says Ketamine Brings Hope to Patients News Source Link While Psychiatrists Turn to Psychedelics, Bakersfield Treatment Center Says Ketamine Brings Hope News to Patients

Comments are closed.